ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

Brachytherapy Prevents Endometrial Cancer Return

June 27, 2008

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

February 25, 1977

Feinstein Reintroduces New National Cancer Act

June 13, 2003